Academy of Medicine Malaysia. 2009. Management of Transfusion Dependent Thalassaemia: Endocrine complication. Malaysia: Ministry of Health.
American Diabetes Association. 2010. Diagnosis and classification of diabetes mellitus. Diabetes care 33(S1): S62–S69. doi: 10.2337/dc10-S062.
Burt MG, Roberts GW, Aguilar-Loza NR, et al. 2011. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. The Journal of Clinical Endocrinology & Metabolism 96(6): 1789–96. doi: 10.1210/jc.2010-2729.
Crippa S, Tamburrino D, Partelli S, et al. 2011. Total pancreatectomy: Indications, different timing, and perioperative and long-term outcomes. Surgery 149(1): 79–86. doi: 10.1016/j.surg.2010.04.007.
Cystic Fibrosis Association of New Zealand. 2011. Standards of Care for Cystic Fibrosis in New Zealand. New Zealand: Medical Advisory Committee of Cystic Fibrosis Association of New Zealand.
International Society for Pediatric and Adolescent Diabetes. 2000. ISPAD consensus guidelines for the management of type 1 diabetes mellitus in children and adolescents. In Swift P (ed): ISPAD Consensus Guidelines for the Management of Type 1 Diabetes Mellitus in Children and Adolescents. Zeist, Netherlands: Med- forum (p 123).
Juszczak A, Owen K. 2014. Identifying subtypes of monogenic diabetes. Diabetes Management 4(1): 49–61. doi: 10.2217/dmt.13.59.
Levin K, Madsen J, Petersen I, et al. 2013. Telemedicine diabetes consultations are cost-effective, and effects on essential diabetes treatment parameters are similar to conventional treatment: 7-year results from the Svendborg Telemedicine Diabetes Project. Journal of Diabetes Science and Technology 7(3): 587–95.
Li MJ, Peng SSF, Lu MY, et al. 2014. Diabetes mellitus in patients with thalassemia major. Pediatric Blood & Cancer 61(1): 20–4. doi: 10.1002/pbc.24754.
Moran A, Brunzell C, Cohen RC, et al. 2010. Clinical care guidelines for cystic fibrosis–related diabetes. Diabetes Care 33(12): 2697–708. doi: 10.2337/dc10-1768.
New Zealand Society for the Study of Diabetes. 2012. Monogenic Diabetes: A guideline for New Zealand healthcare practitioners. New Zealand: NZSSD.
Northern California Comprehensive Thalassemia Center. 2012. Standards of Care Guidelines for Thalassemia: Endocrine dysfunction. Oakland: Children’s Hospital and Research Centre Oakland.
Stevens C, Dinkel S, Catanzaro J. 2011. The complex dual diagnosis of diabetes and cancer. Clinical Journal of Oncology Nursing 15(6): 654–8. doi: 10.1188/11.CJON.654-658.
The UK Cystic Fibrosis Trust Diabetes Working Group. 2004. Management of Cystic Fibrosis Related Diabetes Mellitus. Retrieved from www.cysticfibrosis.org.uk/media/82028/diabetes-mellitus-management-jun04.pdf.
Toledo FG, Triola A, Ruppert K, et al. 2012. Telemedicine consultations: An alternative model to increase access to diabetes specialist care in underserved rural communities. JMIR Research Protocols 1(2): e14. doi: 10.2196/resprot.2235.
Tzoulis P, Shah F, Jones R, et al. 2014. Joint diabetes thalassaemia clinic: An effective new model of care. Hemoglobin 38(2): 104–10. doi: 10.3109/03630269.2013.862541.
SWEET. 2010. Report from EU Project 2007104: Better control in pediatric and adolescent diabetes in the EU: Working to create centres of reference (SWEET) – Recommendations for diabetes care and treatment in pediatric centres of reference in the EU 2009 (pp 1–73). EU: SWEET. Retrieved from www.sweet-project.eu/relaunch/images/WP/WP2final.pdf.
Dostları ilə paylaş: |